News

Professor Heather Pinkett of the US Northwestern University and Pfizer's Dr Dafydd Owen will headline the event staged at the ACC in Liverpool from 21–22 October. Pinkett, associate professor at ...
This followed the Ploug Group at the University of Copenhagen Biotech Research & Innovation Centre’s receipt of two new mass photometer and MassFluidix HC systems to study proteins involved in disease ...
The process begins with swelling Tentagel S resin in DMF, preheating and Fmoc deprotection using 20% Piperidine in DMF. A reduction in resin volume marks the deprotection step, tracked on the VBFR’s ...
The Chinese firm will act as sole distribution partner for Atelerix products in China, that enable storage and transport of temperature-sensitive biomaterials without freezing. Atelerix’s patented ...
Pharmaron will validate CN Bio’s PhysioMimix technology across existing applications and aid integration of organ-on-a-chip technologies into its platform. The initial collaboration will prioritise ...
Dr Dirk Mörmann, managing director of the Endress+Hauser Level+Pressure competence centre, was killed in a car accident while returning from a business meeting, said the company. He took over as head ...
The instrument advances a field which is often regulators are usually fixed and manually or electronically adjustable through the external control of gas pressure. Vapourtec MD Duncan Guthrie ...
Vapourtec’s eBPR is a self-contained, electronically adjustable back pressure regulator that does n… ...
The Biorepository, based on the Queen Elizabeth University Hospital campus, stores and provides access to a wide range of human tissue for use in valuable medical research by doctors and scientists ...
The firm recently completed a refurbishment supervised by lab fit-out consultants Sandell Group at its Herald Court premises at the University of Warwick Science Park. In addition to expanding ...
Dr Michael Murray becomes chair of the company board while Dr Nel Moore joins Glox’s scientific advisory board. New chair Murray is the principal at Murray International Partners, with almost nearly ...
The programme is aimed at early-stage biotech companies focused on novel drug targets and transformational medicines in cardiometabolic diseases, rare blood and rare endocrine disorders. Candidates ...